Traws Pharma Financial Overview
Traws Pharma's market cap is currently $9.91M. The company's EPS TTM is $-0.34; its P/E ratio is 0.05; Traws Pharma is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-1.91. See an overview of income statement, balance sheet, and cash flow financials.
